Future Science OA is an esteemed open-access journal published by FUTURE SCI LTD, dedicated to advancing knowledge in the fields of biotechnology and medicine. Established in 2015, this journal has rapidly gained recognition within the scientific community, evidenced by its impressive ranking in both General Medicine (Rank #100/636, 84th percentile) and Biotechnology (Rank #145/311, 53rd percentile) as per Scopus metrics. With a Q2 category quartile in both fields as of 2023, Future Science OA provides a vital platform for researchers, professionals, and students to share groundbreaking research and innovative ideas. Notably, being an open-access journal allows for a wider dissemination of knowledge, ensuring equal access to high-quality research for practitioners and scholars alike. Based in the United Kingdom, Future Science OA is committed to fostering collaboration and dialogue within the scientific community, making it a cornerstone resource for advancing the future of the life sciences.

Global Journal of Medical Pharmaceutical and Biomedical Update, published by SCIENTIFIC SCHOLAR LLC, is a premier platform dedicated to advancing knowledge in the fields of medicine, pharmaceuticals, and biomedical sciences. With an E-ISSN of 2765-8910, this journal aims to foster innovative research and insightful discussions by providing open access to high-quality peer-reviewed articles. It serves as an invaluable resource for researchers, professionals, and students alike, ensuring that the latest advancements, methodologies, and findings are accessible to a diverse audience. Located at 50, Woodgreen Dr, Pittsford, NY 14534, the journal prioritizes the dissemination of critical information that addresses the evolving challenges faced in healthcare and biomedical research, ultimately contributing to the betterment of global health outcomes.

The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

Cancer Research and Treatment is a premier academic journal published by the Korean Cancer Association that focuses on advancing scientific knowledge and clinical practices in the fields of cancer research and oncology. With an ISSN of 1598-2998 and an E-ISSN of 2005-9256, the journal showcases cutting-edge research articles, clinical trials, and comprehensive reviews that address the multifaceted challenges in cancer treatment and management. Published in South Korea, this journal has established itself as a critical resource, evidenced by its Q1 rank in Oncology and Q2 rank in Cancer Research, reflecting its influence and stature within the academic community. The impact of research disseminated through Cancer Research and Treatment is underscored by its significant percentile rankings in Scopus, with notable positions in both the pharmaceutical and biological sectors. This journal aims to bridge the gap between laboratory research and clinical application, providing a platform for researchers, healthcare professionals, and students to enhance their understanding of cancer-related innovations and therapeutic strategies. Readers will benefit from rich content that not only discusses the latest advancements but also engages with pressing global health issues related to cancer.

Cancer Biology & Medicine is a distinguished Open Access journal published by the China Anti-Cancer Association, dedicated to advancing research and understanding in the fields of Cancer Research and Oncology. Since its inception in 2012, the journal has provided a vital platform for the dissemination of high-quality research, evidenced by its impressive ranking within the Q1 and Q2 categories of oncology and cancer research as of 2023. With a significant impact factor and a Scopus ranking of #64 in Medicine/Oncology and #55 in Biochemistry, Genetics, and Molecular Biology, it plays a crucial role in shaping the future of cancer biology. By offering open access to its content, the journal ensures that pivotal research findings are readily available to researchers, professionals, and students globally, thereby fostering collaboration and innovation in cancer research. Situated in Tianjin, China, this journal is poised at the frontier of oncology research, making a significant impact through its rigorous peer-reviewed articles that address critical challenges in the field.

Advances in Medical Sciences is a peer-reviewed journal published by Elsevier Urban & Partner Sp. z o.o., dedicated to fostering advancements in the field of medicine and healthcare. Established in 2006, this esteemed journal has become a vital resource for researchers, professionals, and students alike, ranking in the Q2 category for Medicine (Miscellaneous) in 2023 and achieving an impressive 84th percentile in the Scopus rankings for General Medicine, placing it at 99 out of 636 journals. With a focus on publishing high-quality research and comprehensive reviews, this journal serves as a platform for disseminating innovative findings that push the boundaries of medical science. Although open access options are not currently available, the journal's rigorous standards ensure that every published article contributes significantly to the global medical community and promotes the understanding of contemporary medical challenges. Located in Wroclaw, Poland, the journal continues to engage a wide readership, driving forward the dialogue in various facets of medical research.

Cancer Research, published by the American Association for Cancer Research, is a premier journal in the field of oncology, renowned for its commitment to advancing cancer research since its inception in 1941. With an impressive impact factor reflecting its vital role in the field, this journal consistently ranks in the Q1 quartile for both Cancer Research and Oncology, positioning it among the top 7.5% of journals in these categories. The journal serves as a crucial platform for researchers, professionals, and students to disseminate and gain insights into groundbreaking studies that shape our understanding of cancer biology, prevention, diagnosis, and treatment. While it is not an open-access publication, its rigorous peer-review process ensures that only high-quality research is published, thus maintaining a standard of excellence in the scientific community. With a strong legacy and an ever-expanding influence, Cancer Research continues to be essential for anyone dedicated to the fight against cancer, showcasing cutting-edge research that drives scientific discovery and innovation.

BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, published by Elsevier Masson SAS Éditeur, is a distinguished journal dedicated to the field of medicine, specifically focusing on various aspects of medical research and advancements. With its inception dating back to 1947, this journal has served as a vital platform for the dissemination of scholarly articles, reviews, and case studies, contributing significantly to the knowledge base within the medical community. Although it is indexed in the Q4 category for medicine (miscellaneous) and has a Scopus rank of #444/636, the journal maintains a key role in promoting ongoing education and discussion among researchers and professionals. The journal does not currently offer Open Access options, allowing for a traditional subscription model that appeals to institutions and individuals seeking comprehensive resources. With a commitment to addressing contemporary medical dilemmas and fostering innovation, the BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE is an essential resource for scholars and practitioners aiming to stay abreast of the latest developments in the field.

CHINESE MEDICAL JOURNAL, published by Lippincott Williams & Wilkins, is a distinguished platform within the field of medicine, providing a vital forum for the dissemination of innovative research and clinical findings since its inception in 1946. With its open access model established in 2000, the journal ensures that critical medical advancements and insights are accessible to a global audience, fostering collaboration and continuous learning among researchers, healthcare professionals, and students alike. The journal’s impressive Q1 ranking in Medicine (miscellaneous), alongside its remarkable Scopus rank of #40 out of 636 in General Medicine, underscores its influential presence in the medical community, promoting high-quality research that advances health outcomes. As it converges historical and contemporary research, the CHINESE MEDICAL JOURNAL plays an essential role in bridging academic inquiry with practical medical application, emphasizing its commitment to improving global healthcare through rigorous scholarship and excellence.